Findings

What do systematic reviews say?

22 questions · 25 findings · 4 reviews · Skin

Sort:Best matchNewest Highest certainty Download CSV

No studies found 2 · 8%GRADE not reported 0 · 0%Very low 0 · 0%Low 7 · 28%Moderate 13 · 52%High 3 · 12%

Topical imiquimod 5% (3 times/week) + meglumine antimoniate (IVMA) (20 mg/kg/d for 20 days) vs placebo + IVMA

Adverse effects (number of participants who had the event) · People with American cutaneous leishmaniasis

1 finding from 1 review

Interventions for American cutaneous and mucocutaneous leishmaniasis 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 80 participants
High

Topical imiquimod 5% (3 times/week) + meglumine antimoniate (IVMA) (20 mg/kg/d for 20 days) vs placebo + IVMA

Recurrence ‐ not measured · People with American cutaneous leishmaniasis

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for American cutaneous and mucocutaneous leishmaniasis 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found